The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries

Viruses. 2021 Nov 29;13(12):2391. doi: 10.3390/v13122391.

Abstract

This review aims to explore the role and value of serology testing in the context of COVID-19 immunization policies in Latin American countries and the barriers and challenges to the adequate use and uptake of this tool. It builds on a review of the academic literature, evidence, and existing policies, and includes a multistage process of discussion and feedback by a group of five experts. Regional and country-level evidence and resources from five focus countries-Argentina, Brazil, Chile, Colombia, and Mexico-were collected and analyzed. This review contains an overview of (1) the impact of the SARS-CoV-2 pandemic, the variants of concern and current testing strategies, (2) the introduction of COVID-19 vaccination, (3) the potential use of serology testing to support immunization initiatives, (4) the current frameworks for the use of serology testing in the region, and (5) the barriers and challenges to implementing serology testing in the context of COVID-19 immunization policies, including a discussion on the potential actions required to address these barriers and facilitate the uptake of this strategy in the region. Stakeholders can use elements of this document to guide timely decision-making, raise awareness, and inspire further studies.

Keywords: COVID-19; Latin America; SARS-CoV-2; antibody tests; diagnostic tests; health policy; immunization; pandemic; serology tests; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Viral
  • Argentina
  • Brazil
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 Serological Testing*
  • COVID-19 Vaccines / immunology*
  • Chile
  • Colombia
  • Health Policy*
  • Humans
  • Immunization / standards*
  • Latin America
  • Mexico
  • Pandemics
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines